A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

por Zhou, Qing, Wu, Lin, Hu, Pei, An, Tongtong, Zhou, Jianying, Zhang, Li, Liu, Xiao-Qing, Luo, Feng, Zheng, Xin, Cheng, Ying, Yang, Nong, Li, Junling, Feng, Jifeng, Han, Baohui, Song, Yong, Wang, Kai, Zhang, Li, Fang, Jian, Zhao, Hong, Shu, Yongqian, Lin, Xiao-Yan, Chen, Zhihong, Gan, Bin, Xu, Wan-Hong, Tang, Wei, Zhang, Xiaoying, Yang, Jin-Ji, Xu, Xiao, Wu, Yi-Long
Publicado 2022